Senior lawyer and former Tata Trusts board member Darius Khambata has defended his previous criticism of the Tata Sons board's process regarding the re-appointment of N Chandrasekaran as Chairman. Khambata also addressed fellow trustees Vijay Singh and Venu Srinivasan, accusing them of reversing their stance on the issue of listing Tata Sons.
Earlier this month, Khambata stated that the Tata Sons board's September 17 decision to reappoint Chandrasekaran harmed the company's reputation. In response, Singh and Srinivasan challenged Khambata on multiple fronts, including Chandrasekaran's re-appointment, the proposed listing of Tata Sons, and allegations that he orchestrated changes in the board of the Sir Dorabji Tata Trust.
Addressing the developments in a statement on Tuesday, Khambata clarified his position on Chandrasekaran's leadership. He explained that impressive performance figures presented in July 2025 led him to vote for the reappointment, and he abided by that resolution. Khambata noted that his subsequent letter on November 2 focused on how the Tata Sons board handled the September 17 proceedings rather than Chandrasekaran's operational performance.
The governance discussion also highlights differing views on leadership timelines. Chandrasekaran had announced in August that he would not seek re-appointment as chairman, leading Tata Trusts to consider forming a selection committee to appoint a successor. Khambata questioned Srinivasan regarding whether he had formally brought Tata Trusts' decision to constitute a selection committee to the attention of the Tata Sons nomination and remuneration committee (NRC).
Srinivasan, who serves on the Tata Sons board and voted in favour of Chandrasekaran's reappointment, has joined Singh in filing complaints with the Charity Commissioner of Maharashtra alleging misgovernance in Tata Trusts. Both trustees have also supported the listing of Tata Sons shares, placing them at odds with Tata Trusts Chairman Noel Tata.
Addressing the listing debate, Khambata stated that his grievance centers on why Singh and Srinivasan repeatedly voted against listing before shifting their position in April 2026. He argued that the merits of listing should be debated during trust meetings rather than through public correspondence or the media. He also dismissed their comparison to Novo Nordisk, arguing that its corporate structure closely resembles Tata Sons and serves as an argument against listing.
Furthermore, Khambata denied allegations that he engineered a strategy to remove Srinivasan and Singh from the Tata Sons board. He pointed out that he voted to reappoint Srinivasan in both October and November 2025, noting that a single vote from him could have blocked the reappointment if a calculated ouster had been planned.
"Corporate governance and transparency at the board level are critical for maintaining stakeholder trust in large legacy institutions. When internal differences among trustees spill over into public disagreements regarding leadership appointments and strategic restructuring like public listings, it creates uncertainty. Resolving these fundamental governance debates through formal institutional channels rather than public correspondence is vital for long-term stability and clear decision-making." — Dr. Shishir Gupta, Founder & CEO, StartupLanes
Recent StartupLanes Articles
Browse through our 30 latest publications on venture capital, startups, and angel investing.